INTRODUCTION
For decades, physicians have tried to influenice intragastric bleeding by physical and pharmacological means. No significant influence by the many approaches could be achieved until recent endoscopic techniques brought a breakthrough by stopping the active bleeding by means of injection of vasoconstricting and sclerosing agents or by heat coagulation [1] [2] [3] [4] [5] [6] . Through these techniques, emergency surgery has been significantly reduced. However, after initial endoscopic hemostasis, rebleeding still occurs in up to 20 percent of patients, and surgery is still necessary in some of these patients.
Optimization of the physiological conditions for hemostasis has been the aim of many pharmacological approaches. None of these approaches has resulted in convincing effects. Reduction of blood flow was one of these approaches for which vasopressin, somatostatin and secretin have been applied [7] [8] [9] [10] [11] . Pepsin inhibitors were introduced with the aim of preventing clot digestion [12] . Inhibition of thrombolysis was tried by the application of tranexamic acid [ 13] . This method was so successful that not only thrombolysis was inhibited, but thrombosis appeared in many parts of the body preventing further use of this approach. Increasing intragastric pH was the final pharmacological approach, which also yielded disappointing results. Antacids, anticholenergics and histamine receptor antagonists were without effects because they could not reliably achieve that elevation of the intragastric pH that is necessary to significantly influence the physiology of hemostasis [14, 15, 16] . The failure of the H2-receptor antagonists is explained by the rapid onset of tolerance towards these drugs [17] [18] [19] .
Green and coworkers have shown that platelet aggregation and blood coagulation are optimal at pH 7.4. Below pH 5.9, platelet aggregation, the initial step of hemostasis, is practically non-existent [20] . Freshly formed clots can easily be digested by gastric pepsin aTo whom all correspondence should be addressed: Prof. Dr [21] . The physiology of hemostasis demands pH values near 7. Only proton pump inhibitors can reliably achieve such values if sufficient doses are given. In early studies with intravenous omeprazole for peptic bleeding, insufficient doses were used. But even these doses showed significant improvement over H2-receptor antagonist therapy [22, 23] . Pharmacokinetic studies with omeprazole concluded that an initial bolus injection of 80 mg followed by a continuous infusion of eight mg per hour was optimal with regard to reduction of intragastric acidity [24, 25, 26] . This dosage regimen was investigated in two large placebo-controlled trials and revealed a significant advantage for the omeprazole therapy with respect to frequency of surgery, need for the endoscopic interventions, the severity and the duration of bleeding, as well as the need for blood transfusions [27, 28] .
The aim of this study was to investigate the optimal mode of application and dosing of intravenously administered pantoprazole, a new proton pump inhibitor.
SUBJECTS AND METHODS Medication
The pantoprazole i.v. formulation (Byk Gulden, Konstanz, Germany) was diluted using 0.9 percent NaCl solution and administered as a dilution of four mg/hr. Bolus injections of 40 mg (10 ml) or 80 mg (20 ml) were administered within two minutes; the longterm infusions were given at a rate of one ml/hr (four mg/hr) or two ml/hr (eight mg/hr). Doses stated in mg refer to pantoprazole as the free acid; the drug, however, was administered as the sodium salt.
Dietary
The subjects took their last meal at 6:00 p.m. the day prior to the investigation and remained fasting throughout the treatment period on the next day. Drinking of water was allowed. pH metry Intragastric pH was continuously recorded using Digitrappers MKII/MKIII (Synectics Medical, Stockholm, Sweden) and glass electrodes M440 (Ingold, Urdorf, Switzerland). The electrodes were calibrated before use at pH 1 and 7 using commercially available buffers. The probe was inserted into the nose and moved downward until the pH turned from neutral to acid (when passing the cardia). The 24 hours each in randomized order. In both periods, separated by a wash-out interval of at least one week, a long-term infusion of eight mg/hr was administered. In one period, the loading dose of 80 mg was given as a bolus injection, in the other period it was given as a two-hour infusion (the latter means that the infusion rate was 48 mg/hr during the first two hours).
RESULTS Intragastric Acidity
The median 24 hour profiles of intragastric pH for the four different modes of application are shown in Figures 1 to 3 . All doses caused a significant reduction of intragastric acidity.
The percentage of time with an intragastric pH above 3, 4, 5 and 6 is shown in Table  1 . Intermittent bolus injections do not significantly raise the pH above 3.0 (Figure 1 ). Continuous infusion with a significantly lower total 24-hour dose is more effective in increasing the intragastric pH, showing an improvement on the second day of infusion (Figure 2 ). Doubling the hourly infusion rate to eight mg per hour achieves the desired breakthrough ( Figure 3 ). There is a marked difference between the effect of the two different loading doses. Spreading the loading dose of 80 mg over two hours results in a retarded pH increase, reaching the optimal pH only after 12 hours. Applying the initial loading dose as a bolus given within two minutes achieves the desired pH within 20 minutes (Figure 3) . The optimal mode of application for reaching the intragastric pH necessary for 12 hours. With the lower infusion rate of four mg/hr, a pH above 6 is also eventually achieved. But this will take some time and therefore is not suitable for emergency application. However, this dose may well be used as a maintenance dose, once a desired intragastric pH has been reached [25] . Intermittent bolus application cannot achieve the necessary intragastric pH because proton pumps are continuously being regenerated [29] . This implies that a proton pump inhibitor should be continuously available in the circulation to inhibit newly generated pumps and thereby inhibit gastric acidity for prolonged periods. In healthy subjects the half-life of proton pump inhibitors in the circulation is approximately 60 minutes. Since it takes four half-lives for a drug to be effectively eliminated from the circulation, bolus injections would have to be given every two to three hours in order to keep sufficient drug in the circulation. Such investigations have not yet been carried out and this mode of application would appear to be very impracticable for clinical use. Currently, continuous infusion is easy to apply and to control.
These data found for pantoprazole are almost identical with those that we and other investigators have found for omeprazole [24, 25, 26] . Both drugs seem to be equivalent when given intravenously.
